Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,143
Closed -$330K – 389
2024
Q3
$330K Sell
3,143
-392
-11% -$45.8K 0.03% 320
2024
Q2
$503K Sell
3,535
-14
-0.4% -$1.61K 0.05% 247
2024
Q1
$396K Sell
3,549
-928
-21% -$111K 0.04% 283
2023
Q4
$581K Buy
4,477
+137
+3% +$18.9K 0.07% 220
2023
Q3
$708K Buy
4,340
+33
+0.8% +$5.8K 0.09% 184
2023
Q2
$790K Buy
4,307
+172
+4% +$24.8K 0.1% 178
2023
Q1
$551K Sell
4,135
-393
-9% -$46.2K 0.07% 223
2022
Q4
$359K Buy
4,528
+608
+16% +$42.8K 0.05% 277
2022
Q3
$237K Buy
+3,920
New +$253K 0.04% 331

Other funds holding ACLS

Intrust Bank's ACLS Position: Q4 2024 in Review

Intrust Bank sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 3,143 shares — an estimated $330K sold.

Intrust Bank first reported a position in ACLS in Q3 2022 and held it in 9 quarters. The position peaked at $790K in Q2 2023. 325 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Intrust Bank reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Intrust Bank sold 3,143 Axcelis shares in Q4 2024, an estimated $330K.
  • Intrust Bank first reported a position in Axcelis in Q3 2022 and held it in 9 quarters.
  • Intrust Bank's Axcelis position peaked at $790K in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Intrust Bank's 13F filing for Q4 2024, filed 12 Feb 2025.